Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
Abstract The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011–2016 was analysed. After excluding patients with missing serum hepcidin (n = 1...
Guardado en:
Autores principales: | Sung Woo Lee, Jeong Min Kim, Hye Jin Lim, Young-Hwan Hwang, Soo Wan Kim, Wookyung Chung, Kook-Hwan Oh, Curie Ahn, Kyu-Beck Lee, Su Ah Sung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d717bc6342a4e6d9e2a4e6bb303b213 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gut–Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing <i>Escherichia coli</i>
por: Yugyeong Lee, et al.
Publicado: (2021) -
Uremic serum damages endothelium by provoking excessive neutrophil extracellular trap formation
por: Hoi Woul Lee, et al.
Publicado: (2021) -
Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease
por: Ji Hye Kim, et al.
Publicado: (2021) -
Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
por: Martina Bielaszewska, et al.
Publicado: (2007) -
Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt
por: Chang Yeob Han, et al.
Publicado: (2016)